| Officer | Age | In this role | Source |
|---|---|---|---|
|
Tim Van Hauwermeiren
Also a director
CEO and executive director
|
53 | Not stated | |
|
Karl Gubitz
CFO
|
56 |
Since 2021
5 years
|
|
|
Karen Massey
COO
|
47 |
Since 2023
3 years
|
|
|
Peter Ulrichts
Chief Scientific Officer
|
46 |
Since 2023
3 years
|
|
|
Malini Moorthy
General Counsel and Corporate Secretary
|
56 |
Since 2022
4 years
|
|
|
Luc Truyen
Chief Medical Officer
|
61 |
Since 2022
4 years
|
|
|
Arjen Lemmen
Vice-President Corporate Development & Strategy
|
41 | Not stated | |
|
Andria Wilk
Global Head of Quality
|
53 |
Since 2020
6 years
|
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Related-party transactions come from the company’s proxy statement. ARGENX SE has not filed one with the SEC.
Loading...